ANTIBACTERIAL CHEMOTHERAPY-INTRODUCTION AND DEVELOPMENT

Antibacterial Chemotherapy refers to the use of any chemical or drug for the treatment of bacterial diseases. It is the part of antimicrobial chemotherapy.
Antimicrobial chemotherapy can be divided into several branches on the basis of type of pathogen, for e.g.
For bacterial pathogen – Antibacterial Chemotherapy
For viral pathogen – Antiviral Chemotherapy
For fungal pathogen – Antifungal Chemotherapy, etc

ANTIMICROBIAL CHEMOTHERAPY –
Chemotherapy may either mean involvement of any drug that fight against any cancerous cell or it may involve the use of any antimicrobial drug to cure diseases caused by infectious microorganisms or pathogens.
Antimicrobial drugs work by different mechanisms for different type of organisms. The overall mechanism by which any antimicrobial drug functions is by interfering with the structure and/or function of microorganisms. They either directly kill microbial cell or function by inhibiting their growth.

DEVELOPMENT OF ANTIMICROBIAL CHEMOTHERAPY
The development of chemotherapy has been known to begin with the successful research of a German physician, Paul Ehrlich (1854-1915).
Ehrlich was always fascinated to learn more about the dyes that bind to and stain the microbial cells. He was sure and stated that one of the dyes could be used as a chemical that would selectively destroy or kill the infectious pathogen inside the human body without making any harm to human cell and he named it “Magic Bullet”. Working more on this, he was able to find that the dye, trypsan red was active against the trypanosome that causes African Sleeping Sickness. Later, Ehrlich with his assistant Sahachiro Hata tested a variety of arsenic-based chemicals on Syphilis-infected rabbits and was successful in finding that Arsphenamine (an arsenic based chemical compound) was active against the Syphilis spirochete which was then made available in the market.
The other German scientist, Domagk in 1927 found the another Magic Bullet to treat diseases. He observed the antimicrobial activity of a synthetic dye, Prontosil Red which was able to cure Streptococcal and Staphylococcal infections with very limited toxicity. Sulfanilamide (one of the active breakdown products of prontosil in body) was the first synthetic antimicrobial drug.

A Synthetic Antimicrobial is a drug that is developed from any type of a chemical compound that is not found in nature.

Penicillin was the first naturally synthesized antibiotic which was initially discovered by a 21 years old French medical student. No one remembered his work until Alexander Fleming in September 1928 accidently rediscovered the antibiotic. The petri plate of Staphylococcus which was inoculated by Fleming was found to develop certain molds which made the clear zone of inhibition of staph-bacterial species around them. It was meant that the mold infected the petri plates even before the bacteria were inoculated. Fleming suggested that the mold (probably the strain of Penicillium notatum) produced a substance which inhibited the bacterial growth surrounding it and hence had an antibacterial property.
Further experiment results concluded that Penicillin was active against streptococci, meningococci and Corynebacterium diphtheriae, which is the causative agent of diphtheria.
The isolation, mass production and purification of penicillin were accomplished by Howard Florey and Ernst Chain for which they got the nobel prize. They found that the penicillin once pured was effectively able to show antimicrobial properties against streptococcal infection in mice.
Later, Dorothy Hodgkin observed and analyzed the structure of various naturally synthesized products using X-rays. Because of her observation on the chemical structure of naturally synthesized penicillin, it was easier for many scientists to produce a variety of semi synthetic penicillin.

A semisynthetic antimicrobial is defined as the chemically modified product of a natural antibiotic.

After the discovery of penicillin, other scientists got the determination for the discovery of more antibiotics by natural or chemical synthesis.
Selman Waksman developed a new antibiotic, Streptomycin which was produced by the actinomycete, Streptomyces griseus. This antibiotic was discovered by the soil microorganisms, particularly bacteria and fungi. It was the first discovery of antibiotic- producing soil microorganism. It was found that streptomycin was successful in treating tuberculosis.
Other microorganisms producing chloramphenicol, neomycin, terramycin and tetracycline were also isolated later.

Dr. Harsh Vardhan calls for developing innovative cooling solutions

Union Minister for Science & Technology, Earth Sciences and Health & Family Welfare, Dr. Harsh Vardhan addressed an Award Ceremony here today to announce the finalists of the ‘Global Cooling Prize’. He called for developing innovative cooling solutions which are energy efficient.  During the ceremony, he said energy efficient and climate friendly cooling solutions are the Government’s priority.
“We recognise the power of innovation to catalyse climate friendly development and growth.  Accordingly, we have bolstered our research, development and innovation efforts to further global climate agenda and strengthened our commitment to accelerate clean energy innovation so that it plays a key role in Mission Innovation.
Dr. Harsh Vardhan said India has been leading from the front in the global campaign to tackle Global Warming and Climate Change. The Prime Minister Shri Narendra Modi had spelled out India’s agenda during the 2015 United Nations Climate Change Conference in Paris, He said. “In fact, the Mission Innovation programme was coined by Shri Narendra Modi,” he added.

 

Dr. Harsh Vardhan said the world today needs an extremely efficient cooling technology, a solution that can sustainably meet the comfort-cooling needs of our growing population without contributing to runaway climate change or costly stresses on already burdened electricity systems.
“It becomes even more relevant for a country like India which is on the path of economic growth and has relatively low penetration of air conditioning.  .  The Government recognises this need and is fully committed to provide “Thermal comfort for all” which has been articulated so well in the India Cooling Action Plan,” he said.
Dr. Harsh Vardhan hoped the finalists of the ‘Global Cooling Prize’ will deliver the prototypes having capability to deliver climate friendly solutions within the broad parameters of energy efficiency and costs.
Speaking on the occasion, Professor Ashutosh Sharma, Secretary Department of Science and Technology (DST), said our goal is to cut carbon footprint by as much as 80 percent and reduce energy consumption by half. The High Commissioner of the United Kingdom to India, Mr. Dominic Asquith also addressed the gathering.
During the ceremony, Dr. Harsh Vardhan presented Awards to the eight finalists of the GCP. The finalists are Daikin Air Conditioning India Pvt. Ltd., Godrej and Boyce Mfg. Co. Ltd., and S&S Design Startup Solution Pvt. Ltd. – all three from India; M2 (Square) Thermal Solutions, Transaera Inc. and Kraton Corporation (in collaboration with IIT Bombay, Infosys and Porus Labs)- all three from the US; Gree Electric Appliances Inc. of Zhuhai, China; and Barocal Ltd of UK.
The eight selected teams showcased a wide range of technology ideas, from smart, hybrid designs of vapour compression technology to smart, hybrid designs of evaporative cooling to solid-state cooling technologies with application of low or no global warming potential refrigerants.
A global coalition led by the Department of Science and Technology, Government of India; Rocky Mountain Institute (RMI)— a leading global research institute; and Mission Innovation — a global initiative of 24 countries and the European Union to accelerate global clean energy innovation — launched the Global Cooling Prize in November, 2018 with the aim of spurring the development of a radically more efficient, climate-friendly residential cooling solution.
Innovation and new technologies in the cooling industry are especially crucial for India, Studies suggest that the cost to the Indian economy due to lost productivity from extreme heat could exceed $450 billion by 2030. While the household ownership of ACs in India today is a mere 7%, the demand for comfort cooling is expected to drive the total stock of room ACs in India to over 1 billion by 2050 — a 40-fold growth from 2016. Growth in the demand for cooling will be dramatic, particularly in urban areas, due to the underlying need for a solution to the problem of heat stress. 
Since its launch, the Prize has received overwhelming international participation — over 2,100 participant registrations were received from innovators, start-ups, research institute, universities, and key Air Conditioning industry manufacturers in over 95 countries. Of these registered entities, 445 teams submitted their preliminary ideas and 139 teams from 31 countries around the globe followed through with their submission of the full Detailed Technical Application. The teams selected to go forth to the next round are being awarded US$ 200,000 each to develop their prototypes, which will then be tested in India in the summer of 2020.
The winner of the Global Cooling Prize will be announced in November, 2020 and awarded more than US$1 million in prize money.
*****